Upcoming Event:
July 9, 2026, 1:00 PM ET (New York)
(Convert this to your time zone)
Summary
The shift toward antibody therapeutics represents a landmark evolution in medicine: moving beyond the broad systemic effects of traditional chemotherapy and small molecule drugs toward a paradigm of high-precision targeting and harnessing the power of the patient’s immune response. By leveraging a significantly longer half-life, binding exclusively to specific antigens, and triggering a wide array of downstream effects, antibody therapeutics promise a more effective approach while reducing the likelihood of off-target toxicity compared to traditional chemotherapy.
In this webinar you will learn:
*NSG is a registered trademark in the USA and other countries
JAX® Webinars are complimentary.
No fees will be charged for registering.
Webinars are 45-50 minutes long, followed by a Q&A session.